A Study of Gebasaxturev (V937) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors (V937-013)
Clinical trial NCT04521621 · TERMINATED
Trial details
- NCT number
- NCT04521621
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-28
- Primary completion
- 2023-07-25
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.